Maxime Dougados (M Dougados)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 66

Top Topics

Rheumatoid Arthritis

Arabidopsis Thaliana

Atopic Dermatitis

Top Venues

Annals of the rheumatic diseases

Rheumatology international

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Moltó, Chris Serrand, Sandrine Alonso, Francis Berenbaum, Pascal Claudepierre, Bernard G Combe, Laure Gossec, Adeline Ruyssen-Witrand, Alain Saraux, Daniel Wendling, Thierry Lequerre, Maxime Dougados
Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort. RMD open 10 (3) (2024)
Clementina López Medina, Filip Van Den Bosch, Désirée Van Der Heijde, Maxime Dougados, Anna Moltó
When usual care is not so usual: protocol violations and generalisability in a treat-to-target strategy trial in axial spondyloarthritis. Arthritis care & research (2024)
Maxime Dougados, Audrey Lardy-Cléaud, Emilie Desfleurs, Pascal Claudepierre, Philippe Goupille, Adeline Ruyssen-Witrand, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study. RMD open 10 (1) (2024)
Juliette M S Drouet, Clementina López Medina, Benjamin Granger, Bruno Fautrel, Robert B M Landewe, Anna Moltó, Cécile Gaujoux-Viala, Uta Kiltz, Maxime Dougados, Laure Gossec
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology international 44 (8) (2024)
Maxime Dougados, Audrey Lardy-Cléaud, Emilie Desfleurs, Pascal Claudepierre, Philippe Goupille, Adeline Ruyssen-Witrand, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study. RMD open 10 (1) (2024)
Clementina López Medina, Anna Moltó, Alexandre Sepriano, Josef S Smolen, Anne Tournadre, Maxime Dougados
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort. RMD open 10 (3) (2024)
Anna Moltó, Clementina López Medina, Alexandre Sepriano, Josef S Smolen, Manouk de Hooge, Miranda van Lunteren, Victoria Navarro-Compán, Daniel Wendling, Maxime Dougados
Sacroiliac radiographic progression over 10 years in axSpA: data from the DESIR inception cohort. Annals of the rheumatic diseases (2024)
Elodie Portier, Sylvie Chevret, Anouk Walter Petrich, Adeline Ruyssen-Witrand, Maxime Dougados, Anna Moltó
Factors Associated With Treatment Pathways in Early Axial Spondyloarthritis: A Multistate Analysis of the 10-Year Follow-Up of the DESIR Cohort. The Journal of rheumatology 51 (4) (2024)
Elodie Portier, Sylvie Chevret, Anouk Walter Petrich, Adeline Ruyssen-Witrand, Maxime Dougados, Anna Moltó
Factors Associated With Treatment Pathways in Early Axial Spondyloarthritis: A Multistate Analysis of the 10-Year Follow-Up of the DESIR Cohort. The Journal of rheumatology (2024)
Juliette M S Drouet, Clementina López Medina, Benjamin Granger, Bruno Fautrel, Robert B M Landewe, Anna Moltó, Cécile Gaujoux-Viala, Uta Kiltz, Maxime Dougados, Laure Gossec
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology international 44 (8) (2024)
Anna Moltó, Chris Serrand, Sandrine Alonso, Francis Berenbaum, Pascal Claudepierre, Bernard G Combe, Laure Gossec, Adeline Ruyssen-Witrand, Alain Saraux, Daniel Wendling, Thierry Lequerre, Maxime Dougados
Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort. RMD open 10 (3) (2024)
Clementina López Medina, Anna Moltó, Alexandre Sepriano, Josef S Smolen, Anne Tournadre, Maxime Dougados
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort. RMD open 10 (3) (2024)
Clementina López Medina, Anna Moltó, Alexandre Sepriano, Josef S Smolen, Anne Tournadre, Maxime Dougados
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort. RMD open 10 (3) (2024)
Elodie Portier, Maxime Dougados, Adeline Ruyssen-Witrand, Anna Moltó
Impact of pregnancy on sacroiliac imaging in women with axial spondyloarthritis: results of the analysis of the DESIR cohort. Scandinavian journal of rheumatology (2024)
Maxime Dougados, Audrey Lardy-Cléaud, Emilie Desfleurs, Pascal Claudepierre, Philippe Goupille, Adeline Ruyssen-Witrand, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study. RMD open 10 (1) (2024)
Maxime Dougados, Audrey Lardy-Cléaud, Emilie Desfleurs, Pascal Claudepierre, Philippe Goupille, Adeline Ruyssen-Witrand, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study. RMD open 10 (1) (2024)
Juliette M S Drouet, Clementina López Medina, Benjamin Granger, Bruno Fautrel, Robert B M Landewe, Anna Moltó, Cécile Gaujoux-Viala, Uta Kiltz, Maxime Dougados, Laure Gossec
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology international (2024)
Anna Moltó, Chris Serrand, Sandrine Alonso, Francis Berenbaum, Pascal Claudepierre, Bernard G Combe, Laure Gossec, Adeline Ruyssen-Witrand, Alain Saraux, Daniel Wendling, Thierry Lequerre, Maxime Dougados
Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort. RMD open 10 (3) (2024)
Clementina López Medina, Filip E Van den Bosch, Désirée Mfm van der Heijde, Maxime Dougados, Anna Moltó
When Usual Care Is Not So Usual: Protocol Violations and Generalizability in a Treat-to-Target Strategy Trial in Patients With Axial Spondyloarthritis. Arthritis care & research (2024)
Maria Llop, Jordi Gratacós, Mireia Moreno Martínez-Losa, Marta Arevalo Salaet, Joan Calvet, Antoni Berenguer Llergo, Maxime Dougados, Anna Moltó, Clementina López Medina
Sex differential impact of comorbidities in spondyloarthritis: data from COMOSPA study. RMD open 10 (1) (2024)
Maria Llop, Jordi Gratacós, Mireia Moreno Martínez-Losa, Marta Arevalo Salaet, Joan Calvet, Antoni Berenguer Llergo, Maxime Dougados, Anna Moltó, Clementina López Medina
Sex differential impact of comorbidities in spondyloarthritis: data from COMOSPA study. RMD open 10 (1) (2024)
Clementina López Medina, Anna Moltó, Alexandre Sepriano, Josef S Smolen, Anne Tournadre, Maxime Dougados
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort. RMD open 10 (3) (2024)
Clementina López Medina, Anna Moltó, Alexandre Sepriano, Josef S Smolen, Anne Tournadre, Maxime Dougados
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort. RMD open 10 (3) (2024)
Anna Moltó, Clementina López Medina, Alexandre Sepriano, Josef S Smolen, Manouk de Hooge, Miranda van Lunteren, Victoria Navarro-Compán, Daniel Wendling, Maxime Dougados
Sacroiliac radiographic progression over 10 years in axSpA: data from the DESIR inception cohort. Annals of the rheumatic diseases 83 (7) (2024)
Anna Moltó, Chris Serrand, Sandrine Alonso, Francis Berenbaum, Pascal Claudepierre, Bernard G Combe, Laure Gossec, Adeline Ruyssen-Witrand, Alain Saraux, Daniel Wendling, Thierry Lequerre, Maxime Dougados
Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort. RMD open 10 (3) (2024)
Juliette M S Drouet, Clementina López Medina, Benjamin Granger, Bruno Fautrel, Robert B M Landewe, Anna Moltó, Cécile Gaujoux-Viala, Uta Kiltz, Maxime Dougados, Laure Gossec
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology international 44 (8) (2024)
Elodie Portier, Sylvie Chevret, Anouk Walter Petrich, Adeline Ruyssen-Witrand, Maxime Dougados, Anna Moltó
Factors Associated With Treatment Pathways in Early Axial Spondyloarthritis: A Multistate Analysis of the 10-Year Follow-Up of the DESIR Cohort. The Journal of rheumatology 51 (4) (2024)
Josef S Smolen, Robert B M Landewe, Désirée Mfm van der Heijde, Alexandre Sepriano, Oliver M FitzGerald, Mikkel Østergaard, Joanne Homik, Ori Elkayam, J Carter Throne, Margaret J Larché, Gianfranco Ferraccioli, Marina Backhaus, Gilles Boire, Bernard G Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain G Cantagrel, Cornelia F Allaart, Cheryl C M Barnabe, Clifton O Bingham, Dirkjan van Schaardenburg, Hilde Berner Hammer, Rana Dadashova, Edna Hutchings, Joel Paschke, Walter P Maksymowych
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM. Rheumatology (Oxford, England) (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Marta Arevalo Salaet, Clementina López Medina, Mireia Moreno Martínez-Losa, Victoria Navarro-Compan, Joan Calvet Fontova, Maria Llop, Maxime Dougados, Jordi Gratacós
Association between HLA-B27 and peripheral spondyloarthritis phenotype: results from the ASAS perSpA study. RMD open 8 (2) (2023)
Marta Arevalo Salaet, Clementina López Medina, Mireia Moreno Martínez-Losa, Victoria Navarro-Compan, Joan Calvet Fontova, Maria Llop, Maxime Dougados, Jordi Gratacós
Association between HLA-B27 and peripheral spondyloarthritis phenotype: results from the ASAS perSpA study. RMD open 8 (2) (2023)
Haseeb Ahmad Chaudhary, Clementina López Medina, Muhammad Asim Khan, Maxime Dougados, Marina Magrey
Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study. RMD open 9 (3) (2023)
Désirée Mfm van der Heijde, Anna Moltó, Josef S Smolen, Jüergen Braun, Maxime Dougados, Floris A van Gaalen, Lianne S Gensler, Robert Davies Inman, Robert B M Landewe, Helena Marzo-Ortega, Victoria Navarro-Compán, Andri Phoka, Denis Poddubnyy, Mikhail Protopopov, John D Reveille, Martin Rudwaleit, Percival Sampaio-Barros, Alexandre Sepriano, Joachim Sieper, Filip E Van den Bosch, Irene van der Horst-Bruinsma, Pedro M Machado, Xenofon Baraliakos
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature. Annals of the rheumatic diseases (2023)
Joanna Kedra, Philippe Dieudé, Caroline Giboin, Hubert Marotte, Carine Salliot, Thierry Schaeverbeke, Aleth Perdriger, Martin Soubrier, Jacques Morel, Arnaud Constantin, Emmanuelle Dernis, Valérie Royant, Jean-Hugues Salmon, Thao Pham, Jacques-Eric Gottenberg, Edouard Pertuiset, Maxime Dougados, Valérie Devauchelle-Pensec, Philippe Gaudin, Grégoire Cormier, Philippe Goupille, Xavier Mariette, Francis Berenbaum, Didier Alcaix, Sid-Ahmed Rouidi, Jean-Marie Berthelot, Agnès Monnier, Christine Piroth, Frédéric Lioté, Vincent Goëb, Cécile Gaujoux-Viala, Isabelle Chary-Valckenaere, David Hajage, Florence Tubach, Bruno Fautrel, null null
Towards the Lowest Efficacious Dose (ToLEDo): Results of a Multicenter Non-Inferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Maxime Dougados, Julien Lucas, Emilie Desfleurs, Pascal Claudepierre, Philippe Goupille, Adeline Ruyssen-Witrand, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas
Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA). RMD open 9 (1) (2023)
Maxime Dougados, Peter C Taylor, Clifton O Bingham, Lara Fallon, Yves Brault, Satrajit Roychoudhury, Lisy Wang, Meriem Kessouri
The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis. RMD open 8 (2) (2023)
Maxime Dougados, Peter C Taylor, Clifton O Bingham, Lara Fallon, Yves Brault, Satrajit Roychoudhury, Lisy Wang, Meriem Kessouri
The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis. RMD open 8 (2) (2023)
Marta Arevalo Salaet, Clementina López Medina, Mireia Moreno Martínez-Losa, Victoria Navarro-Compan, Joan Calvet Fontova, Maria Llop, Maxime Dougados, Jordi Gratacós
Association between HLA-B27 and peripheral spondyloarthritis phenotype: results from the ASAS perSpA study. RMD open 8 (2) (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Helena Santos, Ana Rita Henriques, Pedro M Machado, Clementina López Medina, Maxime Dougados, Helena Canhão, Ana Maria Rodrigues, Fernando Manuel Pimentel-Santos
Determinants of health-related quality of life and global functioning and health in axSpA, pSpA, and PsA: results from the ASAS-PerSpA study. Rheumatology (Oxford, England) (2023)
Maxime Dougados, Peter C Taylor, Clifton O Bingham, Lara Fallon, Yves Brault, Satrajit Roychoudhury, Lisy Wang, Meriem Kessouri
The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis. RMD open 8 (2) (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Marie Vallier, Béatrice Segurens, Elise Larsonneur, Vincent Meyer, Stephanie Ferreira, Christophe Caloustian, Jean-François Deleuze, Maxime Dougados, Mathias Chamaillard, Corinne Miceli-Richard
Characterisation of gut microbiota composition in patients with axial spondyloarthritis and its modulation by TNF inhibitor treatment. RMD open 9 (1) (2023)
Maxime Dougados, Julien Lucas, Emilie Desfleurs, Pascal Claudepierre, Philippe Goupille, Adeline Ruyssen-Witrand, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas
Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA). RMD open 9 (1) (2023)
Maxime Dougados, Christina Charles-Schoeman, Zoltán Szekanecz, Jon T Giles, Steven R Ytterberg, Deepak L Bhatt, Gary G Koch, Ivana Vranic, Joseph Wu, Cunshan Wang, Kenneth Kwok, Sujatha Menon, Carol A Connell, Arne Yndestad, Jose L Rivas, Maya H Buch
Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme. Annals of the rheumatic diseases (2023)
Maxime Dougados, Julien Lucas, Emilie Desfleurs, Pascal Claudepierre, Philippe Goupille, Adeline Ruyssen-Witrand, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas
Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA). RMD open 9 (1) (2023)
Kastriot Kastrati, Daniel Aletaha, Gerd-Rüdiger R Burmester, Eva Chwala, Christian Dejaco, Maxime Dougados, Iain B McInnes, Angelo Ravelli, Naveed Sattar, Tanja Alexandra Stamm, Tsutomu Takeuchi, Michael Trauner, Désirée Mfm van der Heijde, Marieke J H Voshaar, Kevin L Winthrop, Josef S Smolen, Andreas Kerschbaumer
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases. RMD open 8 (2) (2022)
Christina Charles-Schoeman, Maya H Buch, Maxime Dougados, Deepak L Bhatt, Jon T Giles, Steven R Ytterberg, Gary G Koch, Ivana Vranic, Joseph Wu, Cunshan Wang, Kenneth Kwok, Sujatha Menon, Jose L Rivas, Arne Yndestad, Carol A Connell, Zoltán Szekanecz
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance. Annals of the rheumatic diseases (2022)
Daniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, Christian Dejaco, Maxime Dougados, Iain B McInnes, Naveed Sattar, Tanja Alexandra Stamm, Tsutomu Takeuchi, Michael Trauner, Désirée Mfm van der Heijde, Marieke Voshaar, Kevin L Winthrop, Angelo Ravelli, Neil Betteridge, Gerd-Rüdiger R Burmester, Johannes W J Bijlsma, Vivian Bykerk, Roberto Caporali, Ernest H S Choy, Catalin Codreanu, Bernard Combe, Mary K Crow, Maarten P T de Wit, Paul Emery, Roy M Fleischmann, Cem Gabay, Merete Lund Hetland, Kimmie L Hyrich, AnnaMaria Iagnocco, John Dudley Isaacs, Joel M Kremer, Xavier Mariette, Peter A Merkel, Eduardo F Mysler, Peter Nash, Michael T Nurmohamed, Karel Pavelka, Gyula Poor, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S Smolen
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the rheumatic diseases (2022)
Joanna Kedra, Alexandre Lafourcade, Bernard Combe, Maxime Dougados, David Hajage, Bruno Fautrel
Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort. RMD open 8 (1) (2022)
Diego Benavent, Dafne Capelusnik, Josef S Smolen, Anna Moltó, Clementina López Medina, Maxime Dougados, Victoria Navarro-Compán
Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study. RMD open 8 (2) (2022)
Jüergen Braun, Uta Kiltz, Atul Deodhar, Tetsuya Tomita, Maxime Dougados, Rebecca Bolce, David Sandoval, Chen-Yen Lin, Jessica Walsh
Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST. RMD open 8 (2) (2022)
Marion Pons, Sylvie Chevret, Karine Briot, Maria-Antonietta d'Agostino, Christian Roux, Maxime Dougados, Anna Moltó
Evaluation of long-term TNFi effectiveness after a first switch in early axial spondyloarthritis considering time-varying prescription bias: an inverse-probability weighting analysis of the DESIR cohort. RMD open 8 (1) (2022)
Keisuke Ono, Kishimoto Mitsumasa, Gautam A Deshpande, Sho Fukui, Satoshi Kawaai, Haruki Sawada, Minoru Matsuura, Valeria Rios Rodriguez, Fabian Proft, Kurisu Tada, Naoto Tamura, Yoshinori Taniguchi, Ayako Hirata, Hideto Kameda, Shigeyoshi Tsuji, Yuko Kaneko, Hiroaki Dobashi, Tadashi Okano, Yoichiro Haji, Akimichi Morita, Masato Okada, Yoshinori Komagata, Clementina López Medina, Anna Moltó, Maxime Dougados, Tadakazu Hisamatsu, Tetsuya Tomita, Shinya Kaname
Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis. Rheumatology international 42 (10) (2022)
Victoria Navarro-Compán, Anne Boel, Annelies Boonen, Phillip J Mease, Maxime Dougados, Uta Kiltz, Robert B M Landewe, Xenofon Baraliakos, Wilson Bautista-Molano, Praveena Chiowchanwisawakit, Hanne Dagfinrud, Lara Fallon, Marco Garrido-Cumbrera, Lianne Gensler, Bassel Kamal ElZorkany, Nigil Haroon, Elenore Judy B Uy, Pedro M Machado, Walter Maksymowych, Anna Moltó, Natasha de Peyrecave, Denis Poddubnyy, Mikhail Protopopov, Josef S Smolen, In-Ho Song, Salima van Weely, Désirée Mfm van der Heijde
Instrument selection for the ASAS core outcome set for axial spondyloarthritis. Annals of the rheumatic diseases (2022)
Maxime Dougados, Julien Lucas, Emilie Desfleurs, Cédric Lukas, Alain Saraux, Anne Tournadre, Adeline Ruyssen-Witrand, Daniel Wendling, Philippe Goupille, Pascal Claudepierre
Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France. RMD open 8 (1) (2022)
Astrid Dauchez, Maxime Dougados, Mathilde Kemula, Elodie Regnier, Selim Aractingi, Anna Moltó
Evaluation of the prevalence of musculoskeletal conditions in consecutive patients with skin psoriasis: a descriptive cross-sectional study. Rheumatology international 42 (4) (2022)
Emilce Edith Schneeberger, Gustavo Citera, Dario Ponce de Leon, Annette E Szumski, Kenneth Kwok, Mariel Cutri, Maxime Dougados
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial. The Journal of rheumatology 49 (10) (2022)
Elodie Portier, Maxime Dougados, Anna Moltó
Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology department. Rheumatology international (2021)
Bassel El-Zorkany, Abir Mokbel, Sherif Mohamed Gamal, Ihsane Hmamouchi, Maxime Dougados
Does smoking affect level of seropositivity in RA? A post-HOC global and inter-country analysis of COMORA cohort. Rheumatology international 41 (4) (2021)
Ricardo Jorge de Oliveira Ferreira, Bruno Fautrel, Alain Saraux, Cécile Gaujoux-Viala, Anne-Christine Rat, Francis Guillemin, José António Pereira Da Silva, Maxime Dougados, Laure Gossec
Patient Global Assessment of Disease Activity and Radiographic Progression in Early Arthritis: Three-Year Results From the ESPOIR Cohort. Arthritis care & research 73 (9) (2021)
Anne Boel, Victoria Navarro-Compán, Annelies Boonen, Phillip J Mease, Uta Kiltz, Maxime Dougados, Robert B M Landewe, Désirée Mfm van der Heijde
Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey. The Journal of rheumatology 48 (12) (2021)
Victoria Furer, Christien Rondaan, Marloes W Heijstek, Nancy Agmon-Levin, Sander van Assen, Marc Bijl, Ferry C Breedveld, Raffaele D'Amelio, Maxime Dougados, Meliha Crnkic Kapetanovic, Jacob M van Laar, Annette de Thurah, Robert B M Landewe, Anna Moltó, Ulf Müller-Ladner, Karen Schreiber, Leo Smolar, Jim Walker, Klaus Warnatz, Nicolaas M Wulffraat, Ori Elkayam
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Annals of the rheumatic diseases 79 (1) (2019)
Victoria Furer, Christien Rondaan, Marloes Heijstek, Sander van Assen, Marc Bijl, Nancy Agmon-Levin, Ferdinand C Breedveld, Raffaele D'Amelio, Maxime Dougados, Meliha Crnkic Kapetanovic, Jacob M van Laar, Annette de Thurah, Robert B M Landewe, Anna Moltó, Ulf Müller-Ladner, Karen Schreiber, Leo Smolar, Jim Walker, Klaus Warnatz, Nico M Wulffraat, Ori Elkayam
Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD open 5 (2) (2019)